Hyaluronidase Power Injection Market - Top Companies and Manufacturers

Companies Dominating the Hyaluronidase Power Injection Market

Argenx SE
- Company Overview
- Business Planning
- Main Product Offerings
- Financial Execution
- Main Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
PrimaPharma, Inc.,
Halozyme, Inc.
Bausch & Lomb Incorporated
The Cooper Companies Inc.,
Sun Pharmaceutical Industries Ltd.
STEMCELL Technologies Inc.
Shijiazhuang Yiang Technology Co., Ltd.
Calzyme
Dermax Medical Technology (Hebei) Co., Ltd.

Browse Key Market Insights with Data Illustration:

Hyaluronidase Power Injection Market Size Forecasts 2036

In the News

Argenx SE, an international immunology organization that works to modify the lives of people with serious autoimmune diseases, reported affirmative topline information from the Phase 3 ADAPT-SC study testing subcutaneous (SC) efgartigimod (1000 mg efgartigimod-PH20) as a therapy for generalized myasthenia gravis (gMG). Argenx delivered a biologics approval application (BLA) to the US FDA.
The Food and Drug Administration (FDA) released a letter sanctioning the emergency utilization of the Alinity m Resp-4-Plex for the coexisting qualitative detection and distinction of RNA from SARS-CoV-2, influenza A virus (flu A), influenza B virus (flu B), and/or Respiratory Syncytial Virus (RSV) in anterior nasal or nasopharyngeal swab specimens accumulated by a healthcare provider (HCP).

Frequently Asked Questions (FAQ)

The increasing sharpness across various application fields will majorly drive the market growth of the hyaluronidase power injection market.

The market size of the hyaluronidase power injection market is expected to get a CAGR of approximately 9% over the forecast period, i.e., 2024-2036.

The major players in the market are PrimaPharma, Inc., Halozyme, Inc., Bausch & Lomb Incorporated, The Cooper Companies Inc., Sun Pharmaceutical Industries Ltd., STEMCELL Technologies Inc., Shijiazhuang Yiang Technology Co., Ltd., Calzyme, Dermax Medical Technology (Hebei) Co., Ltd., Takeda Pharmaceuticals Co Limited, Janssen Global Services, LLC, Astellas Pharma Inc., Seagen Inc.

The animal-derived hyaluronidase segment is anticipated to reap the largest market size with almost 55% by the end of 2036 and demonstrate substantial growth scopes.

The market in the North American region is expected to have the largest market share by the end of 2036 and provide more business opportunities in the future.

Hyaluronidase Power Injection Market - Top Companies and Manufacturers

Companies Dominating the Hyaluronidase Power Injection Market

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the hyaluronidase power injection market?

What would be the CAGR of the hyaluronidase power injection market over the forecast period?

Who are the major players dominating the hyaluronidase power injection market?

Which segment captures the largest market size in the source segment of the hyaluronidase power injection market?

Which region will provide more business opportunities for the growth of the hyaluronidase power injection market in the future?